Deepening international exchanges and cooperation in traditional Chinese medicine is an effective way to build a global community of health. For many years，Guangzhou Pharmaceutical Holdings Limited （GPHL） has been committed to creating traditional Chinese medicine products with Chinese characteristics and advantages，strengthening international technological cooperation，actively promoting the international layout of traditional Chinese medicine，and constantly exploring overseas markets. In 2021，GPHL has become the world’s first Fortune 500 company with traditional Chinese medicine as its main business，which is making positive contributions to the internationalization of traditional Chinese medicine. Through several international development strategies such as scientific research，international certification，academic exchanges，and joint promotion，GPHL’s representative product “Huatuo Zaizao Pills” has been registered or sold in 29 countries or regions，and has been at the forefront of Chinese patent medicine exports for 11 consecutive years. GPHL has provided valuable experience for the international innovation and development of Chinese medicine，including increasing investment in scientific and technological research，actively participating in international certification，selecting products according to local conditions，and creating a win-win situation with strong alliances. Looking forward to the future，traditional Chinese medicine industry should further strengthen international technological cooperation，connect with international standard systems，promote the spread of traditional Chinese medicine culture，so as to contribute to deepening international exchanges of traditional Chinese medicine and building a global community of health.